Sign In
Buy TRRSF
Trisura Group Earnings Calls
| Release date | Aug 06, 2026 |
| EPS estimate | $0.546 |
| EPS actual | - |
| Revenue estimate | 539.226M |
| Revenue actual | - |
| Expected change | +/- 1.18% |
| Release date | Feb 12, 2026 |
| EPS estimate | $0.522 |
| EPS actual | $0.546 |
| EPS Surprise | 4.60% |
| Revenue estimate | 549.265M |
| Revenue actual | 577.537M |
| Revenue Surprise | 5.15% |
| Release date | Nov 06, 2025 |
| EPS estimate | $0.513 |
| EPS actual | $0.796 |
| EPS Surprise | 55.17% |
| Revenue estimate | 535.403M |
| Revenue actual | 575.98M |
| Revenue Surprise | 7.58% |
| Release date | Aug 07, 2025 |
| EPS estimate | $0.521 |
| EPS actual | $0.561 |
| EPS Surprise | 7.68% |
| Revenue estimate | 646.898M |
| Revenue actual | 558.091M |
| Revenue Surprise | -13.73% |
Last 4 Quarters for Trisura Group
Below you can see how TRRSF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 07, 2025 |
| Price on release | $30.06 |
| EPS estimate | $0.521 |
| EPS actual | $0.561 |
| EPS surprise | 7.68% |
| Date | Price |
|---|---|
| Aug 01, 2025 | $30.13 |
| Aug 04, 2025 | $29.00 |
| Aug 05, 2025 | $30.10 |
| Aug 06, 2025 | $30.27 |
| Aug 07, 2025 | $30.06 |
| Aug 08, 2025 | $30.65 |
| Aug 11, 2025 | $31.02 |
| Aug 12, 2025 | $30.86 |
| Aug 13, 2025 | $30.72 |
| 4 days before | -0.241% |
| 4 days after | 2.20% |
| On release day | 1.97% |
| Change in period | 1.96% |
| Release date | Nov 06, 2025 |
| Price on release | $26.26 |
| EPS estimate | $0.513 |
| EPS actual | $0.796 |
| EPS surprise | 55.17% |
| Date | Price |
|---|---|
| Oct 31, 2025 | $27.19 |
| Nov 03, 2025 | $27.10 |
| Nov 04, 2025 | $26.85 |
| Nov 05, 2025 | $26.73 |
| Nov 06, 2025 | $26.26 |
| Nov 07, 2025 | $26.91 |
| Nov 10, 2025 | $28.02 |
| Nov 11, 2025 | $27.83 |
| Nov 12, 2025 | $28.36 |
| 4 days before | -3.42% |
| 4 days after | 8.00% |
| On release day | 2.48% |
| Change in period | 4.30% |
| Release date | Feb 12, 2026 |
| Price on release | $32.79 |
| EPS estimate | $0.522 |
| EPS actual | $0.546 |
| EPS surprise | 4.60% |
| Date | Price |
|---|---|
| Feb 06, 2026 | $32.21 |
| Feb 09, 2026 | $32.50 |
| Feb 10, 2026 | $32.50 |
| Feb 11, 2026 | $32.50 |
| Feb 12, 2026 | $32.79 |
| Feb 13, 2026 | $37.27 |
| Feb 17, 2026 | $36.25 |
| Feb 18, 2026 | $36.25 |
| Feb 19, 2026 | $34.82 |
| 4 days before | 1.80% |
| 4 days after | 6.19% |
| On release day | 13.66% |
| Change in period | 8.10% |
| Release date | Aug 06, 2026 |
| Price on release | - |
| EPS estimate | $0.546 |
| EPS actual | - |
| Date | Price |
|---|---|
| May 27, 2026 | $30.00 |
| May 28, 2026 | $30.15 |
| May 29, 2026 | $29.66 |
| Jun 01, 2026 | $29.97 |
| Jun 02, 2026 | $29.22 |
Trisura Group Earnings Call Transcript Summary of Q4 2025
Trisura reported strong 2025 results driven by profitable, specialty-focused underwriting and continued North American expansion. Key financials: operating EPS of $0.75 in Q4 and $2.85 for the year, operating ROE of 17%, gross written premiums of $786 million in Q4 (+10% YoY), net insurance revenue up ~12% YoY, and an 85% combined ratio for the quarter (84.9% for the year). Book value per share rose 18% to $19.42, leaving the company on track for a $1 billion book value target by 2027. Business highlights: Surety led growth (+36% premium in Q4) with the company now ranking among the top 30 U.S. Surety writers; Warranty grew 17% and is expected to continue mid-teens growth; U.S. programs grew (Q4 +17%) with an 81% combined ratio and are expected to grow mid- to high-single digits next year. Capital and investments: the investment portfolio performed well (net investment income +25% in Q4), the balance sheet is conservatively positioned and highly capitalized (debt-to-capital ~12.7%), and management has internal capital earmarked to support U.S. expansion. Outlook: management expects mid-teens premium growth in Trisura Specialty with combined ratios in the mid-80s, stable durability in earnings driven by underwriting plus investment income, and opportunistic inorganic activity consistent with risk/return thresholds.
